Acute respiratory failure
Therapeutic area
Pulmonology
Rare disease
No
- Definition
- Life-threatening respiratory failure that develops rapidly. Causes include injury, sepsis, drug overdose, and pancreatitis. It manifests with dyspnea and cyanosis and may lead to cardiovascular shock.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Acute respiratory failure
- Therapeutic area
- Pulmonology
- acute respiratory failure
- acute respiratory failure
- respiratory failure, acute
- All therapeutic areas
- Pulmonology
- Severity
- Severe
- MONDO ID
- MONDO:0001208
- Parent condition
- MONDO:0020683
Related records
Broader conditions (8)
- Acute disease
- Disease
- Disease by body system or component
- Human disease
- Lower respiratory tract disorder
- Lung disorder
- Respiratory failure
- Respiratory system disorder
Narrower conditions (8)
- Acute respiratory distress syndrome
- Adult acute respiratory distress syndrome
- High altitude pulmonary edema
- Neonatal respiratory failure
- Newborn respiratory distress syndrome
- Pediatric acute respiratory distress syndrome
- Pulmonary edema
- Respiratory distress syndrome in premature infants
Trials (287)
- "VARIABLE-PSV" Study
- A Check-list Including Lung Ultrasound for ED Patients With ARF
- A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure
- A Pilot Study of Combined Cycle Ergometry and Amino Acids in the ICU
- A Prospective Observational Cohort Study of Awake Prone Position Ventilation Strategy in Patients With Acute Respiratory Failure
- A Randomised Controlled Trial of High-Flow Nasal Oxygen Versus Standard Oxygen Therapy in Critically Ill Immunocompromised Patients
- A Study of Communication Between Clinicians, Patients, and Families in the Intensive Care Unit (ICU)
- Acute DYSPnea in the Emergency Department: Diagnostic Value of Point-of-care UltraSound
- Adjusted Ventilatory Assist (NAVA-NIV) in Infants: Short-term Physiological Study
- Advanced Respiratory Monitoring and Oxygen Therapy in Chronically Ill Patients With Acute Respiratory Failure
- Airway Inflammatory Response During Illness in Children With Respiratory Failure
- AKI Biomarkers in Coronavirus(COVID)-19
- ARrest RESpiraTory Failure From PNEUMONIA
- Assessing Ventilator Safety in Patients on Pressure-Support Ventilation
- Assessment of Ventilation Parameters for Extubation Prediction in ICU
- Asymmetric High-flow Nasal Cannula (HFNC) vs Standard HFNC for Post Extubation High-risk Group
- Bed Side Assessment in Patients With Acute Respiratory Failure Under Invasive Mechanical Ventilation
- BELLRICU PROJECT: Precision Medicine in Respiratory Intermediate Care Units
- Better Arterial Cannulation Technique With Different Hemodynamics
- Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
Drugs in development (3)
- Amino acids Phase 2
- Dexmedetomidine Phase 2
- Tozorakimab Phase 3
Other linked drugs (2)
- Ketamine
- Thiamine